Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 7
2005 12
2006 7
2007 15
2008 15
2009 12
2010 12
2011 16
2012 20
2013 18
2014 20
2015 25
2016 19
2017 19
2018 23
2019 25
2020 16
2021 22
2022 25
2023 25
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Assessing Endoscopic Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy: Development and Validation of a Highly Accurate Convolutional Neural Network.
Williams H, Thompson HM, Lee C, Rangnekar A, Gomez JT, Widmar M, Wei IH, Pappou EP, Nash GM, Weiser MR, Paty PB, Smith JJ, Veeraraghavan H, Garcia-Aguilar J. Williams H, et al. Among authors: weiser mr. Ann Surg Oncol. 2024 May 3. doi: 10.1245/s10434-024-15311-y. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38700799
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with Chemoradiation.
Rosen R, Quezada-Diaz FF, Gönen M, Karagkounis G, Widmar M, Wei IH, Smith JJ, Nash GM, Weiser MR, Paty PB, Cercek A, Romesser PB, Sanchez-Vega F, Adileh M, Roth O'Brien D, Hajj C, Williams VM, Shcherba M, Gu P, Crane C, Saltz LB, Garcia Aguilar J, Pappou E. Rosen R, et al. Among authors: weiser mr. J Clin Med. 2024 Apr 9;13(8):2156. doi: 10.3390/jcm13082156. J Clin Med. 2024. PMID: 38673429 Free PMC article.
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant Therapy.
Beets NRA, Verheij FS, Williams H, Omer DM, Lin ST, Qin LX, Beets GL, Beets-Tan RGH, Wei IH, Widmar M, Pappou EP, Weiser MR, Nash GM, Smith JJ, Paty PB, Miranda J, Kim TH, Gollub MJ, Garcia-Aguilar J. Beets NRA, et al. Among authors: weiser mr. Ann Surg. 2024 Apr 22. doi: 10.1097/SLA.0000000000006305. Online ahead of print. Ann Surg. 2024. PMID: 38647132
Tumour deposits are independently associated with recurrence in colon cancer.
Hakki L, Khan A, Do E, Gonen M, Firat C, Vakiani E, Shia J, Widmar M, Wei IH, Smith JJ, Pappou EP, Nash GM, Paty PB, Garcia-Aguilar J, Weiser MR. Hakki L, et al. Among authors: weiser mr. Colorectal Dis. 2024 Mar;26(3):459-465. doi: 10.1111/codi.16873. Epub 2024 Jan 23. Colorectal Dis. 2024. PMID: 38263577
Anal Adenocarcinoma Treated in the Era of Total Neoadjuvant Therapy and Nonoperative Management.
Feferman Y, Rosen RY, Gebran S, Yuval JB, Kerioui M, Gönen M, Wei IH, Widmar M, Nash GM, Weiser MR, Paty PB, Hajj C, Roth O'Brien DA, Romesser PB, Crane CH, Smith JJ, Garcia Aguilar J, Pappou EP. Feferman Y, et al. Among authors: weiser mr. Dis Colon Rectum. 2024 Apr 1;67(4):496-504. doi: 10.1097/DCR.0000000000003113. Epub 2023 Dec 21. Dis Colon Rectum. 2024. PMID: 38127627
Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumors.
Verheij FS, Yuval JB, Kok NFM, Lin ST, Qin LX, Omer DM, Thompson HM, Wei IH, Widmar M, Pappou EP, Weiser MR, Nash GM, Smith JJ, Paty PB, Beets GL, Garcia-Aguilar J. Verheij FS, et al. Among authors: weiser mr. Eur J Surg Oncol. 2024 Jan;50(1):107294. doi: 10.1016/j.ejso.2023.107294. Epub 2023 Nov 23. Eur J Surg Oncol. 2024. PMID: 38039906
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.
Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, Thompson HM, Yuval JB, Kim JK, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Guillem JG, Temple L, Goodman KA, Segal NH, Cercek A, Yaeger R, Nash GM, Widmar M, Wei IH, Pappou EP, Weiser MR, Paty PB, Smith JJ, Wu AJ, Gollub MJ, Saltz LB, Garcia-Aguilar J. Verheij FS, et al. Among authors: weiser mr. J Clin Oncol. 2024 Feb 10;42(5):500-506. doi: 10.1200/JCO.23.01208. Epub 2023 Oct 26. J Clin Oncol. 2024. PMID: 37883738 Clinical Trial.
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.
Harrold EC, Foote MB, Rousseau B, Walch H, Kemel Y, Richards AL, Keane F, Cercek A, Yaeger R, Rathkopf D, Segal NH, Patel Z, Maio A, Borio M, O'Reilly EM, Reidy D, Desai A, Janjigian YY, Murciano-Goroff YR, Carlo MI, Latham A, Liu YL, Walsh MF, Ilson D, Rosenberg JE, Markowitz AJ, Weiser MR, Rossi AM, Vanderbilt C, Mandelker D, Bandlamudi C, Offit K, Berger MF, Solit DB, Saltz L, Shia J, Diaz LA Jr, Stadler ZK. Harrold EC, et al. Among authors: weiser mr. Nat Med. 2023 Oct;29(10):2458-2463. doi: 10.1038/s41591-023-02544-9. Epub 2023 Oct 16. Nat Med. 2023. PMID: 37845474
313 results